Insider · CIK 0001272353

LAWRENCE DAVID

Reports to the SEC for 2 companies · HAWTHORNE, NY

sec.gov

Transactions

Companies

Filings

CIK

0001272353

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2020-12-01	Acorda Therapeutics, Inc.F Tax Payment	Chief, Bus. Ops & PAO	FTax Payment	−1,141 sh	$0.65	−$737.542	13,811
2020-11-09	Acorda Therapeutics, Inc.F Tax Payment	Chief, Bus. Ops & PAO	FTax Payment	−1,024 sh	$0.86	−$880.538	14,952
2020-09-17	Acorda Therapeutics, Inc.A Award	Chief, Bus. Ops & PAO	AAward	+3,015 sh	—	—	15,976
2019-12-02	Acorda Therapeutics, Inc.S Sale	Chief, Bus. Ops & PAO	SSale	−1,176 sh	$1.60	−$1,879.954	12,961
2019-11-07	Acorda Therapeutics, Inc.Employee Stock Option (right to buy)A Award	Chief, Bus. Ops & PAO	AAward	+80K sh	—	—	80,000
2019-03-08	Acorda Therapeutics, Inc.A Award	Chief, Bus. Ops & PAO	AAward	+9,045 sh	—	—	14,137
2019-03-08	Acorda Therapeutics, Inc.Employee Stock Option (right to buy)A Award	Chief, Bus. Ops & PAO	AAward	+15.1K sh	—	—	15,075
2019-02-22	Acorda Therapeutics, Inc.S Sale	Chief, Bus. Ops & PAO	SSale	−761 sh	$13.18	−$10K	5,092
2018-12-22	Acorda Therapeutics, Inc.A Award	Chief, Bus. Ops & PAO	AAward	+2,200 sh	—	—	5,853
2018-12-03	Acorda Therapeutics, Inc.S Sale	Chief, Bus. Ops & PAO	SSale	−2,493 sh	$20.55	−$51.2K	3,653
2018-11-05	Acorda Therapeutics, Inc.F Tax Payment	Chief, Bus. Ops & PAO	FTax Payment	−747 sh	$20.28	−$15.1K	6,146
2018-09-10	Acorda Therapeutics, Inc.A Award	Chief, Bus. Ops & PAO	AAward	+2,200 sh	—	—	6,893
2018-06-12	Acorda Therapeutics, Inc.S Sale	Chief, Bus. Ops & PAO	SSale	−300 sh	$32.68	−$9,804.99	4,693
2018-06-12	Acorda Therapeutics, Inc.S Sale	Chief, Bus. Ops & PAO	SSale	−3,131 sh	$31.65	−$99.1K	4,993
2018-06-08	Acorda Therapeutics, Inc.S Sale	Chief, Bus. Ops & PAO	SSale	−400 sh	$29.61	−$11.8K	8,844
2018-06-08	Acorda Therapeutics, Inc.S Sale	Chief, Bus. Ops & PAO	SSale	−20 sh	$33.10	−$662	8,124
2018-06-08	Acorda Therapeutics, Inc.Employee Stock Option (right to buy)M Exercise/Conversion	Chief, Bus. Ops & PAO	MExercise/Conversion	−5,120 sh	—	—	0
2018-06-08	Acorda Therapeutics, Inc.S Sale	Chief, Bus. Ops & PAO	SSale	−500 sh	$30.58	−$15.3K	8,344
2018-06-08	Acorda Therapeutics, Inc.S Sale	Chief, Bus. Ops & PAO	SSale	−200 sh	$31.90	−$6,380	8,144
2018-06-08	Acorda Therapeutics, Inc.M Exercise/Conversion	Chief, Bus. Ops & PAO	MExercise/Conversion	+5,120 sh	$20.59	+$105K	13,244
2018-06-08	Acorda Therapeutics, Inc.S Sale	Chief, Bus. Ops & PAO	SSale	−4,000 sh	$28.41	−$114K	9,244
2018-06-07	Acorda Therapeutics, Inc.S Sale	Chief, Bus. Ops & PAO	SSale	−19.9K sh	$28.02	−$557K	8,124
2018-06-07	Acorda Therapeutics, Inc.Employee Stock Option (right to buy)M Exercise/Conversion	Chief, Bus. Ops & PAO	MExercise/Conversion	−19.9K sh	—	—	5,120
2018-06-07	Acorda Therapeutics, Inc.M Exercise/Conversion	Chief, Bus. Ops & PAO	MExercise/Conversion	+19.9K sh	$20.59	+$409K	28,004
2018-03-08	Acorda Therapeutics, Inc.F Tax Payment	Chief, Bus. Ops & PAO	FTax Payment	−1,766 sh	$25.65	−$45.3K	8,124
2018-02-22	Acorda Therapeutics, Inc.A Award	Chief, Bus. Ops & PAO	AAward	+5,197 sh	—	—	9,890
2018-01-19	Acorda Therapeutics, Inc.M Exercise/Conversion	Chief, Bus. Ops & PAO	MExercise/Conversion	+30.4K sh	$19.81	+$603K	35,111
2018-01-19	Acorda Therapeutics, Inc.S Sale	Chief, Bus. Ops & PAO	SSale	−29.9K sh	$27.58	−$825K	5,193
2018-01-19	Acorda Therapeutics, Inc.S Sale	Chief, Bus. Ops & PAO	SSale	−500 sh	$28.38	−$14.2K	4,693
2018-01-19	Acorda Therapeutics, Inc.Employee Stock Option (right to buy)M Exercise/Conversion	Chief, Bus. Ops & PAO	MExercise/Conversion	−30.4K sh	—	—	0
2018-01-18	Acorda Therapeutics, Inc.S Sale	Chief, Bus. Ops & PAO	SSale	−582 sh	$27.00	−$15.7K	4,693
2018-01-18	Acorda Therapeutics, Inc.M Exercise/Conversion	Chief, Bus. Ops & PAO	MExercise/Conversion	+582 sh	$19.81	+$11.5K	5,275
2018-01-18	Acorda Therapeutics, Inc.Employee Stock Option (right to buy)M Exercise/Conversion	Chief, Bus. Ops & PAO	MExercise/Conversion	−582 sh	—	—	30,418
2017-12-01	Acorda Therapeutics, Inc.S Sale	Chief, Bus. Ops & PAO	SSale	−3,993 sh	$20.51	−$81.9K	4,693
2017-10-09	Acorda Therapeutics, Inc.S Sale	Chief, Bus. Ops & PAO	SSale	−250 sh	$25.40	−$6,350	8,686
2017-03-01	Acorda Therapeutics, Inc.Employee Stock Option (right to buy)A Award	Chief, Bus. Ops & PAO	AAward	+11K sh	—	—	11,000
2017-03-01	Acorda Therapeutics, Inc.A Award	Chief, Bus. Ops & PAO	AAward	+4,400 sh	—	—	8,936
2017-02-09	Acorda Therapeutics, Inc.M Exercise/Conversion	Chief, Bus. Ops & PAO	MExercise/Conversion	+63.2K sh	$22.13	+$1.4M	67,719
2017-02-09	Acorda Therapeutics, Inc.S Sale	Chief, Bus. Ops & PAO	SSale	−63.2K sh	$22.32	−$1.41M	4,536
2017-02-09	Acorda Therapeutics, Inc.Employee Stock Option (right to buy)M Exercise/Conversion	Chief, Bus. Ops & PAO	MExercise/Conversion	−63.2K sh	—	—	0
2016-12-01	Acorda Therapeutics, Inc.S Sale	Chief, Bus. Ops & PAO	SSale	−4,416 sh	$20.74	−$91.6K	4,536
2016-10-07	Acorda Therapeutics, Inc.S Sale	Chief, Bus. Ops & PAO	SSale	−250 sh	$20.82	−$5,205	8,952
2016-06-22	Acorda Therapeutics, Inc.S Sale	Chief, Bus. Ops & PAO	SSale	−500 sh	$25.09	−$12.5K	9,202
2016-06-22	Acorda Therapeutics, Inc.Employee Stock Option (right to buy)M Exercise/Conversion	Chief, Bus. Ops & PAO	MExercise/Conversion	−500 sh	—	—	0
2016-06-22	Acorda Therapeutics, Inc.M Exercise/Conversion	Chief, Bus. Ops & PAO	MExercise/Conversion	+500 sh	$8.50	+$4,250	9,702
2016-03-02	Acorda Therapeutics, Inc.Employee Stock Option (right to buy)A Award	Chief, Bus. Ops & PAO	AAward	+24.3K sh	—	—	24,255
2015-12-18	Acorda Therapeutics, Inc.Employee Stock Option (right to buy)M Exercise/Conversion	Chief, Bus. Ops & PAO	MExercise/Conversion	−17.5K sh	—	—	0
2015-12-18	Acorda Therapeutics, Inc.S Sale	Chief, Bus. Ops & PAO	SSale	−38.5K sh	$40.62	−$1.56M	9,722
2015-12-18	Acorda Therapeutics, Inc.M Exercise/Conversion	Chief, Bus. Ops & PAO	MExercise/Conversion	+21.5K sh	$5.85	+$126K	48,228
2015-12-18	Acorda Therapeutics, Inc.S Sale	Chief, Bus. Ops & PAO	SSale	−520 sh	$41.06	−$21.4K	9,202

Recent filings

Accepted (ET)
Dec 34
LAWRENCE DAVID0001209191-20-061355
SEC(opens sec.gov)
Nov 124
LAWRENCE DAVID0001209191-20-057819
SEC(opens sec.gov)
Sep 214
LAWRENCE DAVID0001209191-20-051240
SEC(opens sec.gov)
Dec 44
LAWRENCE DAVID0001209191-19-058937
SEC(opens sec.gov)
Nov 124
LAWRENCE DAVID0001209191-19-055904
SEC(opens sec.gov)
Mar 124
LAWRENCE DAVID0001209191-19-018794
SEC(opens sec.gov)
Feb 254
LAWRENCE DAVID0001209191-19-012973
SEC(opens sec.gov)
Dec 274
LAWRENCE DAVID0001209191-18-064142
SEC(opens sec.gov)
Dec 64
LAWRENCE DAVID0001209191-18-061106
SEC(opens sec.gov)
Nov 74
LAWRENCE DAVID0001209191-18-057557
SEC(opens sec.gov)
Sep 124
LAWRENCE DAVID0001209191-18-050633
SEC(opens sec.gov)
Jun 134
LAWRENCE DAVID0001209191-18-037359
SEC(opens sec.gov)
Jun 114
LAWRENCE DAVID0001209191-18-036828
SEC(opens sec.gov)

Companies

Address

15 SKYLINE DRIVE

HAWTHORNE, NY, 10532